Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 1:34 pm Sale | 2026-03-13 | 13G | TARSUS PHARMACEUTICALS INC TARS | VANGUARD GROUP INC | 0 0.000% | -2,097,323 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL MANAGEMENT LLC | 1,188,624 2.800% | -1,266,173 (-51.58%) | Filing History |
| 2025-11-14 08:23 am Purchase | 2025-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital LP | 3,000,000 7.110% | 647,040 (+27.50%) | Filing History |
| 2025-08-14 08:08 am Purchase | 2025-06-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW INVESTMENTS LP | 3,424,180 8.100% | 271,839 (+8.62%) | Filing History |
| 2025-07-28 5:00 pm Purchase | 2025-07-21 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital LP | 2,352,960 5.600% | 2,352,960 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL MANAGEMENT LLC | 2,454,797 5.900% | 2,454,797 (New Position) | Filing History |
| 2025-05-07 11:27 am Sale | 2025-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | MORGAN STANLEY MS | 1,943,453 4.700% | -252 (-0.01%) | Filing History |
| 2025-04-24 09:12 am Sale | 2025-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock Inc. BLK | 3,092,735 7.400% | -662,769 (-17.65%) | Filing History |
| 2025-02-13 12:22 pm Sale | 2024-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cowen Financial Products LLC | 1,909,228 4.900% | -2,171 (-0.11%) | Filing History |
| 2024-11-14 4:41 pm Purchase | 2024-11-14 | 13G | TARSUS PHARMACEUTICALS INC TARS | PRUDENTIAL FINANCIAL INC PRU | 2,295,400 6.000% | 2,295,400 (New Position) | Filing History |
| 2024-11-14 4:35 pm Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Paradigm Biocapital Advisors LP | 2,440,445 6.400% | 512,939 (+26.61%) | Filing History |
| 2024-11-14 3:05 pm Sale | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 500,000 1.310% | -1,721,422 (-77.49%) | Filing History |
| 2024-11-12 6:02 pm Unchanged | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | VANGUARD GROUP INC | 2,097,323 5.510% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:12 am Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | JENNISON ASSOCIATES LLC | 2,178,580 5.700% | 2,178,580 (New Position) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock Inc. BLK | 3,755,504 9.900% | 0 (Unchanged) | Filing History |
| 2024-11-06 10:26 am Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Frazier Life Sciences IX, L.P. | 1,587,527 4.200% | 170,370 (+12.02%) | Filing History |
| 2024-11-04 2:00 pm Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | VANGUARD GROUP INC | 2,097,323 5.510% | 2,097,323 (New Position) | Filing History |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock Inc. BLK | 3,755,504 9.900% | 1,240,380 (+49.32%) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL PARTNERS LP | 2,204,797 6.700% | 203,212 (+10.15%) | Filing History |
| 2024-02-14 3:04 pm Purchase | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 2,221,422 6.710% | 485,000 (+27.93%) | Filing History |